Phantom Neuro Inc. — Form D
Phantom Neuro Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-18. The offering totals $19.3M, of which $12.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-03-18
- Form: D
- Accession: 0001919709-25-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $19.3M
- Amount sold: $12.1M
- Remaining: $7.2M
- Investors: 22
- Date of first sale: 2025-03-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-541184
Issuer
- Name: Phantom Neuro Inc.
- CIK: 0001919709
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 507 SOUTH PARK DRIVE, UNIT 1, AUSTIN, TX, 78704
- Phone: 918-497-8722
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Connor Glass | Director | Austin, TX |
| Edward Michael | Director | Tel Aviv, L3 |
| D.A. Wallach | Director | Austin, TX |
| Connor Glass | Executive Officer | Austin, TX |
| Connor Glass | Promoter | Austin, TX |
| Robert Lord | Director | Baltimore, MD |
Other filings by this issuer (1)
More